Skip to main content

Table 1 Overview of all treated cats included in the study

From: Retrospective clinical study on outcome in cats with nasal planum squamous cell carcinoma treated with an accelerated radiation protocol

Nr

Age [years]

Weight [kg]

PCV [%]

Hb [g/dl]

TNM

Grade

Ki 67 [% positive cells]

Ki 67 [score]

DFI [days]

OS [days]

1a

11.0

3.3

36.0

 

T2bN1M0

3

60.6

3

1′432

1′436

2a

8.0

3.3

42.0

12.7

T1bN0M0

2

36.7

2

365

1′227

3a

11.0

4.9

24.0

8.6

T2bN0M0

2

58.7

2

916

1′017

4a

12.0

5.7

34.0

8.6

T1aN0M0

2

50.2

2

456b

460

5a

12.0

3.0

27.0

9.1

T2bN0M0

2

45.3

2

913b

917b

6a

8.5

6.3

35.0

10.2

T1bN0M0

2

63.8

3

2′173b

2′177

7a

8.0

4.7

42.0

14.2

T1aN0M0

2

42.7

2

87

124

8a

14.0

3.1

21.0

7.0

T2bN0M0

1

46.3

2

139

198

9a

8.7

5.1

24.0

8.2

T1aN0M0

1

74.9

3

2′155

2′423

10a

9.5

4.0

29.0

11.6

T2aN0M0

3

81.6

3

656

900

11

12.0

6.9

27.0

8.9

T1bN0M0

2

43.9

2

530b

534

12a

15.0

4.6

27.0

8.6

T1bN0M0

3

71

3

1′721b

1′725

13a

 

4.0

34.0

11.6

T2bN0M0

2

52.7

2

266b

270

14

11.0

4.3

23.0

8.3

T2bN0M0

1

69.5

3

67

74

15

13.0

5.1

39.0

11.8

T1aN0M0

2

51.8

2

538b

542b

16

14.0

3.7

36.0

12.7

T1aN0M0

   

177

874

17

15.0

7.4

33.0

10.9

T1bN0M0

3

41.4

2

858

902

18

11.0

3.6

44.0

15.2

T2bN0M0

3

61.4

3

271

277

19

9.0

4.9

33.0

10.5

T2bN0M0

1

40.4

2

208

362

20

12.0

4.0

31.0

11.0

T2bN0M0

   

363

367

21

7.0

4.1

44.0

15.0

T2bN0M0

   

351

1′514

22

15.0

3.8

30.0

10.5

T1bN0M0

2

71.8

3

726b

730b

23

11.0

4.2

26.0

8.7

T1bN0M0

3

38.1

2

956b

960b

24

11.0

5.6

32.6

6.0

T2bN1M0

2

42.2

2

358

472

25

15.0

4.3

19.0

5.9

T2bNxM0

3

38.5

2

339

490

26

14.0

5.0

36.0

12.4

T2bN0M0

   

641

659

27

10.0

3.9

30.0

10.0

T1bNxM0

1

  

482b

486b

28

11.0

3.9

32.0

11.1

T1bN0M0

   

473

570

29

14.0

3.4

26.0

8.7

T2bN0M0

   

1′460b

1′464

30

13.0

4.9

39.0

13.3

T2bN0M0

   

226

230

31

8.0

4.0

36.0

12.8

T2bN0M0

   

466b

470

32

13.0

5.0

44.2

14.8

T1aN0M0

   

356b

360b

33

11.2

6.1

43.0

14.1

T1aN0M0

   

808b

812b

34

16.0

2.9

45.3

13.6

T2bN0M0

   

346b

350b

35

14.0

7.3

45.1

14.1

T2bN0M0

   

184b

189

36

14.0

4.2

29.3

9.6

T2bN0M0

   

17b

22

37

11.0

3.7

49.7

14.9

T1aN0M0

   

1′078

1′082

38

9.0

5.6

34.6

10.1

T2bN0M0

   

153

195

39

9.0

6.2

37.0

13.0

T2bN0M0

   

1′890b

1′894b

40

14.0

4.7

41.9

13.1

T1bN0M0

   

452b

452b

41

8.0

4.6

36.0

10.9

T1bN0M0

2

40.9

2

728b

732b

42

6.0

5.5

30.7

10.8

T2bN0M0

   

347b

351b

43

5.0

5.0

32.5

10.3

T1bN0M0

   

902b

906

44

12.0

6.1

37.0

9.9

T2aN0M0

   

487b

492

  1. PCV Packed cell volume, Hb Hemoglobin, TNM Modified staging system, x Missing data, DFI Disease free interval, OS Overall survival, acats previously reported [3], with a longer follow-up; bAll deaths were considered events; cats still free of progression, alive at the time of data evaluation or lost to follow-up were censored